Johnson & Johnson JNJ

$270.47 +3.33 (1.25%)

Valuation

Market cap
651,105,152,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
25.08
P/E (forward)
24.03
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
11,925,300
Avg volume
7,611,122
Day's range
$269.47 – $272.50
Shares out
2,407,310,000
Stochastic %K
23%
Beta
0.22
Analysts
Moderate Buy
Price target
$284.24

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Fonss Nov 22, 6:46 AM
$SLS $JNJ $MRK This is my dream scenario. 🏆🏆💰💰 Just play along. If we get acquired, my dream is that it’s either MRK or JNJ. But they won’t get us cheaply. 1) If it’s JNJ, then it’s 1 share + 70 dollars 2)If it’s MRK, then it’s 2 shares + 70 dollars. $350+ Extremely bullish. (I know—it’s a dream, but I think it’s reasonable, given what the SLS could earn in the future.)
0 replies
40MikeMike Nov 22, 6:42 AM
$JNJ what in the bio stonk Saturday night drunkard hype is going on… Bio stonks the OG crypto meme coin pump n dump n pump a chump Take a sniff… Smell that?…. It’s Hype men selling as they are exiting lol
0 replies
RyInvest24 Nov 22, 6:08 AM
$JNJ $SLS IM TAGGING JNJ WITHOUT MERCK CAUSE IM LETTING YALL IN ON THE OFFER FIRST BEFORE I GO TAG ON MERCK SO YALL BEST BE IN THE BOARDROOM SUNDAY MAKING YO DECISION!
0 replies
TooHot_toTouch Nov 22, 5:48 AM
$SLS Is it a 2 horse race or 3 ? $JNJ $MRK $PFE
1 replies
CrazyCajun7 Nov 22, 5:46 AM 0 replies
CrazyCajun7 Nov 22, 5:34 AM 0 replies
rocketwisher Nov 22, 5:33 AM
$SLS its either $JNJ or $MRK.. I dont care. Bring it Sterg.
0 replies
CrazyCajun7 Nov 22, 5:21 AM 0 replies